Zhong Chen

Dr. Zhong Chen


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in BME Frontiers
Verified
Journal Article
Open access
IKImran Ahamed Khan
Imran Ahamed Khan
TYTing Yu
Ting Yu
MYMing Yang
Ming Yang
JLJinliang Liu
Jinliang Liu
ZCZhong Chen
Zhong Chen
Upconversion nanoparticles (UCNPs) are emerging as highly promising nanomaterials due to their exceptional optical properties, enabling diverse applications in biosensing, bioimaging, photodynamic therapy, and drug delivery. However, their potential toxicity should be comprehensively investigated for the safe utilization of UCNPs in several biomedical and environmental applications. This review systematically evaluates the current knowledge on UCNP toxicity from 2008 to 2024, focusing on key toxicological pathways, such as oxidative stress, reactive oxygen species (ROS) production, inflammatory responses, and apoptosis/necrosis, alongside their absorption, distribution, metabolism, and excretion processes and kinetics. Distinctively, this review introduces a bibliometric analysis of UCNP toxicity and biodistribution research, providing a quantitative assessment of publication trends, influential authors, leading institutions, funding agencies, and keyword occurrences. This approach offers a macroscopic perspective on the evolution and current landscape of UCNP safety research, a dimension largely unexplored in existing literature. Furthermore, the review combines mechanistic insights into UCNP toxicity with a critical evaluation of surface modifications, physicochemical properties, and administration routes, presenting a holistic framework for understanding UCNP biosafety. By combining bibliometric data with mechanistic insights, this review provides a data-driven perspective on UCNP-associated risks, actionable strategies for enhancing biosafety through surface engineering, and a forward-looking discussion on regulatory challenges and future directions for UCNP-based technologies. These findings bridge existing gaps in the literature and offer a comprehensive resource for researchers, clinicians, and policymakers, facilitating the safe development and utilization of UCNP-based technologies while establishing robust safety guidelines to mitigate adverse effects on human health and the environment.

1 July 2020 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Closed access
ZCZhong Chen
Zhong Chen
CYCui Yu
Cui Yu
IKImran Ahamed Khan
Imran Ahamed Khan
YTYi Tang
Yi Tang
SLShuai Liu
Shuai Liu
MYMing Yang
Ming Yang

7 February 2022 in Science of The Total Environment
Verified
Journal Article
Closed access
YZYuanyuan Zhang
Yuanyuan Zhang
TLTianjie Li
Tianjie Li
CPChenyuan Pan
Chenyuan Pan
IKImran Ahamed Khan
Imran Ahamed Khan
ZCZhong Chen
Zhong Chen
MYMing Yang
Ming Yang

1 November 2021 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Open access
LZLili Zhang
Lili Zhang
YZYifan Zhang
Yifan Zhang
ZMZhihui Ma
Zhihui Ma
YZYanrong Zhu
Yanrong Zhu
ZCZhong Chen
Zhong Chen
Coronary heart disease (CHD) is a multifactorial disease associated with complicated altered metabolic pathways, especially when it occurs with type 2 diabetes (T2D). Identification of metabolic changes could provide further understanding of the underlying pathological link between with CHD and T2D. In this study, 61 controls, 30 consecutive patients with only T2D, 188 with confirmed CHD among which 50 also having T2D were enrolled. Quantitative 1H nuclear magnetic resonance (1H NMR) based metabonomic approach was used to obtain the plasma metabolic profiles of the study samples. Multivariate principal component analysis and orthogonal partial least-squares discriminant analysis (OPLS-DA) were used to evaluate the differences of metabolites. Compared with controls, there were significant differences in CHD patient with T2D groups including BCAAs (isoleucine, leucine, and valine) and phenylalanine by using quantitative metabolomic profiling (all p < 0.05). With OPLS-DA, the results showed that, compared to CHD patients without T2D, there had higher levels of metabolites for leucine, valine, fumarate, tyrosine, and phenylalanine in the plasma of CHD patients with T2D. Moreover, the CHD patients with T2D showed modified phenylalanine, tyrosine and tryptophan biosynthesis, valine, leucine and isoleucine biosynthesis and degradation compared with CHD patients without T2D. By 1H NMR based quantitative metabolomic method, our findings suggest that T2D has important effects on BCAAs and AAAs metabolism in CHD patients indicating altered cardiac energy metabolism and activated signaling pathway could be potential targets for therapy in CHD disease combined with T2D.

27 August 2024 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Open access
IKImran Ahamed Khan
Imran Ahamed Khan
TYTing Yu
Ting Yu
YLYong Li
Yong Li
CHChengzhang Hu
Chengzhang Hu
XZXiaoyu Zhao
Xiaoyu Zhao
ZCZhong Chen
Zhong Chen
Lanthanide-doped upconversion nanoparticles (Ln-UCNPs) have been considered promising materials for various fields, such as biomedical and industrial applications. However, data and reports regarding its toxicity and environmental risks are scarce. Under these circumstances, data must be obtained to fully understand potential toxicity and adverse outcome pathways. In the present study, the toxicity of uncoated Ln-UCNP cores (NaYF4:Yb, Er) was systematically assessed in zebrafish embryos during early developmental stages. Ln-UCNPs were found to have multiple toxic effects, such as effects on survival rates, delayed hatching times, shorter body lengths, altered heart rates and blood circulation (significantly reduced), and neurobehavioral impairments in response to photoperiod stimulation. Bioimaging showed that Ln-UCNPs were distributed on the chorion, eyes, and skin at 72 hpf. However, it accumulates in the pharynx, esophagus, and intestine after oral administration. Ln-UCNPs disrupt the diversity and abundance of host-associated microorganisms (gut microbiota) leading to an increase in the prevalence of harmful bacteria in zebrafish. Transcriptomic and Ingenuity Pathway Analysis (IPA) predicted Interleukin-8 (IL-8) signaling, neuroinflammation, cardiac hypertrophy signaling pathways, immune and inflammation-related response interferon-gamma (ifnγ), and miR-155 as key mediators in regulatory effects. Based on this, a causal network was built showing the strong links between the induced gene expression of differentially expressed genes (DEGs), such as nitric oxide synthase 2 (nos2) and tumor necrosis factor (tnf) upon Ln-UCNPs treatment, and with the downstream adverse outcomes, in particular, the promotion of apoptosis, liver damage, and inflammatory response. Finally, RT-qPCR analysis confirmed the up-regulated expression of nos2 and tnf in the exposed larvae, consistent with the observation of an increased number of fluorescence-labelled neutrophils and macrophages in lyz: DsRed transgenic zebrafish until 120 hpf exposure, which together demonstrated the proinflammatory effects of Ln-UCNPs on organisms. In conclusion, we illustrated the developmental toxicity, disruption of gut-microbiome, and proinflammatory effects of Ln-UCNP cores on zebrafish, and the causal network from IPA analysis may help further elucidate the adverse outcome pathway of Ln-UCNPs.

10 February 2017 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
YLYafei Li
Yafei Li
ZXZhiyong Xie
Zhiyong Xie
LCLei Chen
Lei Chen
JYJianjun Yan
Jianjun Yan
YMYao Ma
Yao Ma
ZCZhong Chen
Zhong Chen
Early B-cell factor 1 (EBF1) is a transcription factor expressed primarily during early B cell development. Previous studies have shown EBF1 regulates blood glucose and lipid metabolism in mice with diabetes and central adiposity. Recently, a genetic variation (rs36071027) located in an EBF1 gene intron was associated with carotid artery intima-media thickness. However, whether this polymorphism is actually linked with coronary artery disease (CAD) and its severity remains unclear. This study includes 293 CAD cases and 262 controls without CAD. All participants were devided into two groups based on their coronary angiography results. A polymerase chain reaction-ligase detection reaction was used to identify genotypes at rs36071027, and CAD patients were further divided into subgroups with one-, two-, or three-vessel stenosis reflective of CAD severity. The frequency of the rs36071027 TT genotype was significantly higher in CAD cases versus controls (4.8% vs. 1.5%, 95% CI: 1.13-10.81 P = 0.029). Subjects with a variant genotype T allele had an increased risk of CAD compared to C allele carriers (additive model: 95% CI: 1.13-2.23, P = 0.008). After adjustment for cardiovascular risk factors, analysis of the additive and dominant models involving rs36071027 also revealed that T allele carriers had a significantly higher risk for CAD than C allele carriers (additive model: OR 1.56, 95% CI 1.10–2.22, P = 0.013; dominant model: OR 1.60, 95% CI 1.07–2.41, P = 0.023). Furthermore, both diabetes and the CT + TT rs36071027 genotype were significantly associated with three-vessel stenosis. Our results in a Chinese population suggest that the TT genotype and T alleles in rs36071027 in the EBF1 gene are associated with an increased risk of CAD and its severity.